How China’s Black Monday Hit the Top 10 Medtech Firms

Traders work on the floor of the New York Stock Exchange (NYSE) in New York

Major medtech companies got their share of the thumping that U.S. stock markets received amid a “Black Monday” in which Chinese stocks saw their worst decline in eight years, with resulting questions about the Chinese government’s managing of the world’s largest economies.

While the U.S. stock market recovered somewhat after tumbling 1000 points in early-morning trading on August 24, it closed the day down 588.40 points, or 3.57%. It marked the worst single-day decline in the U.S. stock market since August 8, 2011, when the Dow fell 634.76 points, or 5.6%.


About Peter Coffaro 1426 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.